Authors
Loading...
Observational analysis highlights metabolic activity in colorectal cancer, suggesting TP53 status as a predictive biomarker.
Desterke et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: